nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Absence of BRAF-V600E in the human cell lines BONNA-12, ESKOL, HAIR-M, and HC-1 questions their origin from hairy cell leukemia
|
Tiacci, Enrico |
|
|
119 |
22 |
p. 5332-5333 |
artikel |
2 |
An activating intragenic deletion in NOTCH1 in human T-ALL
|
Haydu, J. Erika |
|
|
119 |
22 |
p. 5211-5214 |
artikel |
3 |
A phase 1 study of obinutuzumab induction followed by 2 years of maintenance in patients with relapsed CD20-positive B-cell malignancies
|
Sehn, Laurie H. |
|
|
119 |
22 |
p. 5118-5125 |
artikel |
4 |
A polymorphism in the XPD gene predisposes to leukemic transformation and new nonmyeloid malignancies in essential thrombocythemia and polycythemia vera
|
Hernández-Boluda, Juan-Carlos |
|
|
119 |
22 |
p. 5221-5228 |
artikel |
5 |
Basis of CTLA-4 function in regulatory and conventional CD4+ T cells
|
Tai, Xuguang |
|
|
119 |
22 |
p. 5155-5163 |
artikel |
6 |
CD20 antibodies: type II to tango?
|
van Oers, Marinus H.J. |
|
|
119 |
22 |
p. 5061-5063 |
artikel |
7 |
Cold agglutinin disease with prolymphocytic leukemia
|
Yiu, Richard Cheung |
|
|
119 |
22 |
p. 5069 |
artikel |
8 |
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitors
|
Gonzalez-Nieto, Daniel |
|
|
119 |
22 |
p. 5144-5154 |
artikel |
9 |
Control of murine Ly6Chigh monocyte traffic and immunosuppressive activities by atypical chemokine receptor D6
|
Savino, Benedetta |
|
|
119 |
22 |
p. 5250-5260 |
artikel |
10 |
De Domenico I, Vaughn MB, Yoon D, Kushner JP, Ward DM, Kaplan J. Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations. Blood. 2007;110(10):3780–3783.
|
|
|
|
119 |
22 |
p. 5340 |
artikel |
11 |
Dendritic cells and regulation of graft-versus-host disease and graft-versus-leukemia activity
|
Stenger, Elizabeth O. |
|
|
119 |
22 |
p. 5088-5103 |
artikel |
12 |
Does the NO/sGC/cGMP/PKG pathway play a stimulatory role in platelets?
|
Gambaryan, Stepan |
|
|
119 |
22 |
p. 5335-5336 |
artikel |
13 |
Do not super-excess me!
|
Rivella, Stefano |
|
|
119 |
22 |
p. 5064-5065 |
artikel |
14 |
Editorial Board
|
|
|
|
119 |
22 |
p. i |
artikel |
15 |
Engineering lymph node homing of ex vivo–expanded human natural killer cells via trogocytosis of the chemokine receptor CCR7
|
Somanchi, Srinivas S. |
|
|
119 |
22 |
p. 5164-5172 |
artikel |
16 |
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemia
|
Bhatla, Teena |
|
|
119 |
22 |
p. 5201-5210 |
artikel |
17 |
Evaluation of published single nucleotide polymorphisms associated with acute GVHD
|
Chien, Jason W. |
|
|
119 |
22 |
p. 5311-5319 |
artikel |
18 |
Excess mortality after treatment with fludarabine and cyclophosphamide in combination with alemtuzumab in previously untreated patients with chronic lymphocytic leukemia in a randomized phase 3 trial
|
Lepretre, Stephane |
|
|
119 |
22 |
p. 5104-5110 |
artikel |
19 |
Expression of ABO blood-group genes is dependent upon an erythroid cell–specific regulatory element that is deleted in persons with the Bm phenotype
|
Sano, Rie |
|
|
119 |
22 |
p. 5301-5310 |
artikel |
20 |
Extra-platelet NO and NO+-containing drugs are potent inhibitors of platelet aggregation in humans by cGMP-dependent and cGMP-independent mechanisms
|
Tsikas, Dimitrios |
|
|
119 |
22 |
p. 5337-5339 |
artikel |
21 |
FCA: Forget Chemoimmunotherapy with Alemtuzumab?
|
Hallek, Michael |
|
|
119 |
22 |
p. 5059-5060 |
artikel |
22 |
From famine to feast: sending out the clones
|
Glaubach, Taly |
|
|
119 |
22 |
p. 5063-5064 |
artikel |
23 |
Heme-regulated eIF2α kinase activated Atf4 signaling pathway in oxidative stress and erythropoiesis
|
Suragani, Rajasekhar N.V.S. |
|
|
119 |
22 |
p. 5276-5284 |
artikel |
24 |
HHV-8–encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice
|
Suthaus, Jan |
|
|
119 |
22 |
p. 5173-5181 |
artikel |
25 |
Horning SJ, Juweid ME, Schöder H, et al. Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study. Blood. 2010;115(4):775–777.
|
|
|
|
119 |
22 |
p. 5340 |
artikel |
26 |
Human Langerhans cells use an IL-15R-α/IL-15/pSTAT5-dependent mechanism to break T-cell tolerance against the self-differentiation tumor antigen WT1
|
Romano, Emanuela |
|
|
119 |
22 |
p. 5182-5190 |
artikel |
27 |
Integrated protein quality-control pathways regulate free α-globin in murine β-thalassemia
|
Khandros, Eugene |
|
|
119 |
22 |
p. 5265-5275 |
artikel |
28 |
Meeting the challenge of hematologic malignancies in sub-Saharan Africa
|
Gopal, Satish |
|
|
119 |
22 |
p. 5078-5087 |
artikel |
29 |
Modification of an exposed loop in the C1 domain reduces immune responses to factor VIII in hemophilia A mice
|
Wroblewska, Aleksandra |
|
|
119 |
22 |
p. 5294-5300 |
artikel |
30 |
Monoclonal antibodies against macrophage colony-stimulating factor diminish the number of circulating intermediate and nonclassical (CD14++CD16+/CD14+CD16++) monocytes in rheumatoid arthritis patient
|
Korkosz, Mariusz |
|
|
119 |
22 |
p. 5329-5330 |
artikel |
31 |
Monocytes in HIT: an evolving story
|
McKenzie, Steven E. |
|
|
119 |
22 |
p. 5065-5066 |
artikel |
32 |
Mouse background and IVIG dosage are critical in establishing the role of inhibitory Fcγ receptor for the amelioration of experimental ITP
|
Leontyev, Danila |
|
|
119 |
22 |
p. 5261-5264 |
artikel |
33 |
Novel treatment for congenital FXIII deficiency
|
Kohler, Hans P. |
|
|
119 |
22 |
p. 5060-5061 |
artikel |
34 |
Osteopontin is a prognostic factor for survival of acute myeloid leukemia patients
|
Liersch, Ruediger |
|
|
119 |
22 |
p. 5215-5220 |
artikel |
35 |
PF4/heparin-antibody complex induces monocyte tissue factor expression and release of tissue factor positive microparticles by activation of FcγRI
|
Kasthuri, Raj S. |
|
|
119 |
22 |
p. 5285-5293 |
artikel |
36 |
Phase 1 study results of the type II glycoengineered humanized anti-CD20 monoclonal antibody obinutuzumab (GA101) in B-cell lymphoma patients
|
Salles, Gilles |
|
|
119 |
22 |
p. 5126-5132 |
artikel |
37 |
Programmed vesicle transfer of green fluorescent protein from a stably transduced cell line to primary hematopoietic cells
|
Russell, Thomas B. |
|
|
119 |
22 |
p. 5330-5332 |
artikel |
38 |
Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency
|
Inbal, Aida |
|
|
119 |
22 |
p. 5111-5117 |
artikel |
39 |
Response: inhibition of platelet activation by NO involves both cGMP-dependent and -independent mechanisms
|
Li, Zhenyu |
|
|
119 |
22 |
p. 5339 |
artikel |
40 |
Response: yes, cGMP plays a stimulatory role in platelet activation
|
Li, Zhenyu |
|
|
119 |
22 |
p. 5336-5337 |
artikel |
41 |
RNA-dependent inhibition of ribonucleotide reductase is a major pathway for 5-azacytidine activity in acute myeloid leukemia
|
Aimiuwu, Josephine |
|
|
119 |
22 |
p. 5229-5238 |
artikel |
42 |
Runx1 regulates embryonic myeloid fate choice in zebrafish through a negative feedback loop inhibiting Pu.1 expression
|
Jin, Hao |
|
|
119 |
22 |
p. 5239-5249 |
artikel |
43 |
Sequential gain of mutations in severe congenital neutropenia progressing to acute myeloid leukemia
|
Beekman, Renée |
|
|
119 |
22 |
p. 5071-5077 |
artikel |
44 |
Smad2/Smad3 in endothelium is indispensable for vascular stability via S1PR1 and N-cadherin expressions
|
Itoh, Fumiko |
|
|
119 |
22 |
p. 5320-5328 |
artikel |
45 |
SNPs and GVHD prediction: where to next?
|
Dickinson, Anne M. |
|
|
119 |
22 |
p. 5066-5068 |
artikel |
46 |
Sorafenib treatment of FLT3-ITD+ acute myeloid leukemia: favorable initial outcome and mechanisms of subsequent nonresponsiveness associated with the emergence of a D835 mutation
|
Man, Cheuk Him |
|
|
119 |
22 |
p. 5133-5143 |
artikel |
47 |
Studying c-Myc serine 62 phosphorylation in leukemia cells: concern over antibody cross-reactivity
|
Tibbitts, Deanne C. |
|
|
119 |
22 |
p. 5334-5335 |
artikel |
48 |
The transcription factor Spi-B regulates human plasmacytoid dendritic cell survival through direct induction of the antiapoptotic gene BCL2-A1
|
Karrich, Julien J. |
|
|
119 |
22 |
p. 5191-5200 |
artikel |